Meler-Claramonte, C.; Avilés-Jurado, F.X.; Vilaseca, I.; Terra, X.; Bragado, P.; Fuster, G.; León Vintró, X.; Camacho, M.
Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC. Cancers 2022, 14, 2259.
https://doi.org/10.3390/cancers14092259
AMA Style
Meler-Claramonte C, Avilés-Jurado FX, Vilaseca I, Terra X, Bragado P, Fuster G, León Vintró X, Camacho M.
Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC. Cancers. 2022; 14(9):2259.
https://doi.org/10.3390/cancers14092259
Chicago/Turabian Style
Meler-Claramonte, Carla, Francesc Xavier Avilés-Jurado, Isabel Vilaseca, Ximena Terra, Paloma Bragado, Gemma Fuster, Xavier León Vintró, and Mercedes Camacho.
2022. "Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC" Cancers 14, no. 9: 2259.
https://doi.org/10.3390/cancers14092259
APA Style
Meler-Claramonte, C., Avilés-Jurado, F. X., Vilaseca, I., Terra, X., Bragado, P., Fuster, G., León Vintró, X., & Camacho, M.
(2022). Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC. Cancers, 14(9), 2259.
https://doi.org/10.3390/cancers14092259